ConductScience.org, home

Paper28035964

Rate of Homologous Desensitization and Internalization of the GLP-1 Receptor.

Shaaban G and 2 others. Molecules, 2016. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Rate of Homologous Desensitization and Internalization of the GLP-1 Receptor. Papers, record 28035964. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28035964

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rate of Homologous Desensitization and Internalization of the GLP-1 Receptor.
PubMed
Journal
Molecules
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2025-01-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shaaban GGhina
2Oriowo MMabayoje
3Al-Sabah SSuleiman

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cyclic AMPMajor topic
Glucagon-Like Peptide 1Major topic
Glucagon-Like Peptide-1 Receptor AgonistsMajor topic
Bacterial Proteins
Dose-Response Relationship, Drug
Gene Expression
Genes, Reporter
Glucagon-Like Peptide-1 Receptor
HEK293 Cells
Humans
Kinetics
Luciferases
Luminescent Proteins
Protein Transport
Proto-Oncogene Proteins c-myc
Staining and Labeling
Time Factors
Transgenes

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118445652Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18445652PubMed
215699045Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes.J Biol Chem2005https://conductscience.org/library/papers/15699045PubMed
38838146Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.Mol Endocrinol1996https://conductscience.org/library/papers/8838146PubMed
42836733Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization.Nature1988https://conductscience.org/library/papers/2836733PubMed
525449603Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway.Biochem Pharmacol2015https://conductscience.org/library/papers/25449603PubMed
621445058Retromer terminates the generation of cAMP by internalized PTH receptors.Nat Chem Biol2011https://conductscience.org/library/papers/21445058PubMed
719701185Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.Nat Chem Biol2009https://conductscience.org/library/papers/19701185PubMed
821094896Pleiotropic actions of the incretin hormones.Vitam Horm2010https://conductscience.org/library/papers/21094896PubMed
99212057Internalization and homologous desensitization of the GLP-1 receptor depend on phosphorylation of the receptor carboxyl tail at the same three sites.Mol Endocrinol1997https://conductscience.org/library/papers/9212057PubMed
1016931572Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor.Mol Endocrinol2006https://conductscience.org/library/papers/16931572PubMed
1125191754The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.PLoS One2014https://conductscience.org/library/papers/25191754PubMed
128968491G-protein-coupled receptor kinases and arrestins: regulators of G-protein-coupled receptor sequestration.Biochem Soc Trans1996https://conductscience.org/library/papers/8968491PubMed
1324275181Real-time trafficking and signaling of the glucagon-like peptide-1 receptor.Mol Cell Endocrinol2014https://conductscience.org/library/papers/24275181PubMed
1423684623Pharmacology, physiology, and mechanisms of incretin hormone action.Cell Metab2013https://conductscience.org/library/papers/23684623PubMed
1515561912Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo.Diabetes2004https://conductscience.org/library/papers/15561912PubMed
1615528268Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.Mol Endocrinol2005https://conductscience.org/library/papers/15528268PubMed
1717010343Glucagon-mediated internalization of serine-phosphorylated glucagon receptor and Gsalpha in rat liver.FEBS Lett2006https://conductscience.org/library/papers/17010343PubMed
1819074620The role of incretins in glucose homeostasis and diabetes treatment.Pharmacol Rev2008https://conductscience.org/library/papers/19074620PubMed
1917498508Biology of incretins: GLP-1 and GIP.Gastroenterology2007https://conductscience.org/library/papers/17498508PubMed
202163110beta-Arrestin: a protein that regulates beta-adrenergic receptor function.Science1990https://conductscience.org/library/papers/2163110PubMed

See all 34 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42712076A Biweekly GLP-1R Agonist Designed With Drug-Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability.Diabetes Obes Metab2026https://conductscience.org/library/papers/42712076PubMed
42461990GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight.Circ Res2026https://conductscience.org/library/papers/42461990PubMed
41963534The effects of glucagon-like peptide-1 receptor agonists on sympathetic neuron activity.Hypertens Res2026https://conductscience.org/library/papers/41963534PubMed
41695210Efficacy of celastrol-supplemented diet in overweight and obese dogs: a 24-week randomized controlled trial.Front Vet Sci2025https://conductscience.org/library/papers/41695210PubMed
41673096Liraglutide attenuates aluminum chloride-induced Alzheimer's disease in rats by modulating the oxLDL/LPA/LPAR1 pathway.Commun Biol2026https://conductscience.org/library/papers/41673096PubMed
41552778Glucagon-Like Peptide-1 Receptor Agonists and Alcohol Use: A Real-Word Observational Study in a Large, Integrated Health Care System.Biol Psychiatry Glob Open Sci2026https://conductscience.org/library/papers/41552778PubMed
40201698The C-terminal regions of the GLP-1 and GIP receptors are not the key determinants of their differential arrestin recruitment but modulate the rate of receptor endocytosis.Front Pharmacol2025https://conductscience.org/library/papers/40201698PubMed
40168114Prolonged signaling of backbone-modified glucagon-like peptide-1 analogues with diverse receptor trafficking.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40168114PubMed
36177761Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells.Pharmacol Res Perspect2022https://conductscience.org/library/papers/36177761PubMed
35184645Novel glucagon-like peptide-1 analogue exhibits potency-driven G-protein biased agonism with promising effects on diabetes and diabetic dry eye syndrome.Bioengineered2022https://conductscience.org/library/papers/35184645PubMed
33182425Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells.Int J Mol Sci2020https://conductscience.org/library/papers/33182425PubMed
31330984A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor.Int J Mol Sci2019https://conductscience.org/library/papers/31330984PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADRB2154PubTator's text mininghttps://conductscience.org/library/genes/154NCBI Gene
CAV1857PubTator's text mininghttps://conductscience.org/library/genes/857NCBI Gene
GCG2641PubTator's text mininghttps://conductscience.org/library/genes/2641NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28035964

GET https://conductscience.org/api/papers/v1/28035964/references?page=2